• Resources
  • Blog
  • Journalists
  • Log In
  • Sign Up
  • Data Privacy
  • Send a Release
Cision PR Newswire: news distribution, targeting and monitoring home
  • News
  • Products
    • Overview
    • Distribution by PR Newswire
    • Cision Communications Cloud®
    • Cision IR
    • Sponsored Placement
    • All Products
  • Contact
    • General Inquiries
    • Request a Demo
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices

 

When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • Sponsored Placement
  • All Products
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • All Products
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR

IRT: FDA Product Safety Declaration Misleads Nation -- Again


News provided by

Institute for Responsible Technology

Apr 22, 2015, 05:24 ET

Share this article

Share this article


LOS ANGELES, April 22, 2015 /PRNewswire-USNewswire/ -- The FDA's declaration on March 20th that the genetically engineered non-browning apple and potato "are as safe and nutritious as their conventional counterparts" is only the second time they have "officially" declared a GMO safe; but it turns out that it's not really their official position at all and it misleads the public about their safety review process. Although the two genetically modified organisms did undergo the agency's voluntary consultation, that process is not even designed to provide a scientific determination of safety or official government approval of GMOs.

"Based on the FDA's longstanding GMO policy since 1992," says Jeffrey M. Smith, Executive Director of the Institute for Responsible Technology, "it is the companies themselves who are fully responsible to determine that their GMOs are safe." This is spelled out in the official letters the FDA issues to all GMO producers, including the Okanagan Specialty Fruit company for their apple and to J. R. Simplot for their potato. The letters state unequivocally that the FDA simply recognizes that the companies themselves have concluded their GMOs are safe.

"As with all the other GMO foods on the market," says Steven Druker, author of the new bestselling exposé on GMOs, Altered Genes, Twisted Truth, "the FDA has not performed a genuine scientific assessment that's competent to certify safety – and the manufacturers have not done so either. The voluntary consultation process is mere window dressing designed to create the illusion that such assessments are occurring."

FDA Consultation is Incompetent to Declare Safety

The FDA's press release gives the false impression that the agency used a competent, scientific protocol for its safety review. According to Smith, "Companies can submit whatever data or summaries they want; there are no standards for testing; no requirements for modern analyses; and no adherence to recommendations made by international bodies or scientific organizations." He adds, "Since companies never actually provide raw data from feeding studies, the FDA is not in a position to verify the producers' safety claims."

For food additives, on the other hand, the agency has a complete testing protocol in place to make the determination that there is a "reasonable certainty" the product will not be harmful. But the agency policy does not require GMOs to undergo a food additive evaluation. In fact, the agency does not require GMOs to undergo any safety studies whatsoever and does not require any labeling. According to Druker, who is a public interest attorney, "This lax policy is blatantly illegal." In his book, he describes in detail how it violates the stringent requirements of the US Food, Drug, and Cosmetic Act.

The Fraudulent Basis of FDA Policy

The purported justification for not requiring safety tests was advanced in the 1992 policy, which claimed, "The Agency has no information showing that [GMOs] . . . differ from other foods in any meaningful or uniform way." When FDA was sued by The Alliance for Bio-Integrity in 1998, however, the agency was forced to turn over 44,000 internal documents on GMOs, exposing the fiction. According to Druker, who initiated the lawsuit as the Alliance's Executive Director, "The documents demonstrated that the overwhelming consensus of the FDA's own scientists was the exact opposite of the statement in the policy." Druker says, "In memo after memo, the scientists cautioned that GMOs not only pose different risks than do conventional foods, but that each must be carefully tested in order to protect the public from potential unexpected toxins, allergens, and other harmful substances."

The memos also revealed that the White House was pressuring the Agency to give GMOs easy access to the market, pursuant to a long-standing policy to promote biotechnology. Soon after, the FDA hired Michael Taylor, the former attorney for GMO giant Monsanto, to be in charge of FDA policy. "As the Deputy Commissioner for Policy," says Smith, "Taylor was in charge of FDA's GMO policy when it decided to ignore its own scientists' warnings. He later became Monsanto's Vice President for Government Affairs, and is now back at the FDA as the 'US Food Czar.'"

New Apples and Potatoes Could Damage Human Health

The non-browning apple and potato both employ a relatively new technology in which the genes inserted into the crops produces a double stranded RNA (dsRNA) molecule.  The sequence in the RNA enables it to silence the gene that causes browning when the apple or potato is sliced. The apple will look fresh for 15-18 days, and the potato will similarly dry out before it ever discolors to reveal its age.

Numerous scientists are concerned that if we consume dsRNA in GMOs such as the apple and potato, they might inadvertently silence or alter our genes as well. Studies on bees, mice, and other species have verified this danger. According to a seminal 2013 paper published in Environment International, safety assessments must find out if the dsRNA produced in the genetically engineered food causes an effect on humans, preferably using human cell assays, animal tests and possibly "clinical trials on human volunteers." Unfortunately, there is no indication that the dsRNA used in the apples and potatoes have gone through any of these tests.

In addition, the very process of inserting the new gene into apple and potato cells and then cloning them into GMO plants can cause massive collateral damage in their genomes. This same process produced new or higher levels of allergens and toxins in other GMOs, but again, there's no indication that these potential side effects were ever evaluated either.

Smith, whose Institute provides the free Non-GMO Shopping Guide, urges consumers to avoid the new apples and potatoes, when they are expected to be released in about two years. He offers a petition for consumers to sign, asking food vendors to similarly avoid them.

The Institute for Responsible Technology is a non-profit organization that researches and reports news and information about the health risks of genetically engineered food. 

To read the full text of this release and petition visit, and more detail about double strand RNA www.responsibletechnology.org  

For more information about Steven Druker or Altered Genes, Twisted Truth, contact: 

Adrienne Fontaine; 646-307-6309; [email protected] or Emily Labes; 646-776-5761; [email protected]

Press Contact:
NJ Jaeger, IssueTalk Communications
O: 310-377-0915, M: 310-344-9691
E: [email protected]  

SOURCE Institute for Responsible Technology

Related Links

http://www.responsibletechnology.org

Modal title

Contact Cision

  • Cision Distribution 888-776-0942
    from 8 AM - 9 PM ET

  • Chat with an Expert
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • Cision Communication Cloud®
  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • For Small Business
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • COVID-19 Resources
  • Accessibility Statement
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom

My Services

  • All New Releases
  • Online Member Center
  • ProfNet

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2022 Cision US Inc.